Browsing by Author "Hellings P."

Now showing 1 - 7 of 7
  • No Thumbnail Available
    Item
    MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation
    (Blackwell Publishing Ltd, 2015) Bousquet J.; Schunemann H.J.; Fonseca J.; Samolinski B.; Bachert C.; Canonica G.W.; Casale T.; Cruz A.A.; Demoly P.; Hellings P.; Valiulis A.; Wickman M.; Zuberbier T.; Bosnic-Anticevitch S.; Bedbrook A.; Bergmann K.C.; Caimmi D.; Dahl R.; Fokkens W.J.; Grisle I.; Lodrup Carlsen K.; Mullol J.; Muraro A.; Palkonen S.; Papadopoulos N.; Passalacqua G.; Ryan D.; Valovirta E.; Yorgancioglu A.; Aberer W.; Agache I.; Adachi M.; Akdis C.A.; Akdis M.; Annesi-Maesano I.; Ansotegui I.J.; Anto J.M.; Arnavielhe S.; Arshad H.; Baiardini I.; Baigenzhin A.K.; Barbara C.; Bateman E.D.; Beghé B.; Bel E.H.; Ben Kheder A.; Bennoor K.S.; Benson M.; Bewick M.; Bieber T.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Boner A.L.; Boulet L.P.; Bonini M.; Bonini S.; Bosse I.; Bourret R.; Bousquet P.J.; Braido F.; Briggs A.H.; Brightling C.E.; Brozek J.; Buhl R.; Burney P.G.; Bush A.; Caballero-Fonseca F.; Calderon M.A.; Camargos P.A.M.; Camuzat T.; Carlsen K.H.; Carr W.; Cepeda Sarabia A.M.; Chavannes N.H.; Chatzi L.; Chen Y.Z.; Chiron R.; Chkhartishvili E.; Chuchalin A.G.; Ciprandi G.; Cirule I.; Correia De Sousa J.; Cox L.; Crooks G.; Costa D.J.; Custovic A.; Dahlen S.E.; Darsow U.; De Carlo G.; De Blay F.; Dedeu T.; Deleanu D.; Denburg J.A.; Devillier P.; Didier A.; Dinh-Xuan A.T.; Dokic D.; Douagui H.; Dray G.; Dubakiene R.; Durham S.R.; Dykewicz M.S.; El-Gamal Y.; Emuzyte R.; Fink Wagner A.; Fletcher M.; Fiocchi A.; Forastiere F.; Gamkrelidze A.; Gemicioʇlu B.; Gereda J.E.; González Diaz S.; Gotua M.; Grouse L.; Guzmán M.A.; Haahtela T.; Hellquist-Dahl B.; Heinrich J.; Horak F.; Hourihane J.O.B.; Howarth P.; Humbert M.; Hyland M.E.; Ivancevich J.C.; Jares E.J.; Johnston S.L.; Joos G.; Jonquet O.; Jung K.S.; Just J.; Kaidashev I.P.; Kalayci O.; Kalyoncu A.F.; Keil T.; Keith P.K.; Khaltaev N.; Klimek L.; Koffi N'Goran B.; Kolek V.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kuna P.; Kvedariene V.; Lambrecht B.; Lau S.; Larenas-Linnemann D.; Laune D.; Le L.T.T.; Lieberman P.; Lipworth B.; Li J.; Louis R.; Magard Y.; Magnan A.; Mahboub B.; Majer I.; Makela M.J.; Manning P.; De Manuel Keenoy E.; Marshall G.D.; Masjedi M.R.; Maurer M.; Mavale-Manuel S.; Melén E.; Melo-Gomes E.; Meltzer E.O.; Merk H.; Miculinic N.; Mihaltan F.; Milenkovic B.; Mohammad Y.; Molimard M.; Momas I.; Montilla-Santana A.; Morais-Almeida M.; Mösges R.; Namazova-Baranova L.; Naclerio R.; Neou A.; Neffen H.; Nekam K.; Niggemann B.; Nyembue T.D.; O'Hehir R.E.; Ohta K.; Okamoto Y.; Okubo K.; Ouedraogo S.; Paggiaro P.; Pali-Schöll I.; Palmer S.; Panzner P.; Papi A.; Park H.S.; Pavord I.; Pawankar R.; Pfaar O.; Picard R.; Pigearias B.; Pin I.; Plavec D.; Pohl W.; Popov T.A.; Portejoie F.; Postma D.; Potter P.; Price D.; Rabe K.F.; Raciborski F.; Radier Pontal F.; Repka-Ramirez S.; Robalo-Cordeiro C.; Rolland C.; Rosado-Pinto J.; Reitamo S.; Rodenas F.; Roman Rodriguez M.; Romano A.; Rosario N.; Rosenwasser L.; Rottem M.; Sanchez-Borges M.; Scadding G.K.; Serrano E.; Schmid-Grendelmeier P.; Sheikh A.; Simons F.E.R.; Sisul J.C.; Skrindo I.; Smit H.A.; Solé D.; Sooronbaev T.; Spranger O.; Stelmach R.; Strandberg T.; Sunyer J.; Thijs C.; Todo-Bom A.; Triggiani M.; Valenta R.; Valero A.L.; Van Hage M.; Vandenplas O.; Vezzani G.; Vichyanond P.; Viegi G.; Wagenmann M.; Walker S.; Wang D.Y.; Wahn U.; Williams D.M.; Wright J.; Yawn B.P.; Yiallouros P.K.; Yusuf O.M.; Zar H.J.; Zernotti M.E.; Zhang L.; Zhong N.; Zidarn M.; Mercier J.
    Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for integrated care pathways, innovation in clinical trials and, above all, patient empowerment. MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) is a simple system centred around the patient which was devised to fill many of these gaps using Information and Communications Technology (ICT) tools and a clinical decision support system (CDSS) based on the most widely used guideline in allergic rhinitis and its asthma comorbidity (ARIA 2015 revision). It is one of the implementation systems of Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Three tools are used for the electronic monitoring of allergic diseases: a cell phone-based daily visual analogue scale (VAS) assessment of disease control, CARAT (Control of Allergic Rhinitis and Asthma Test) and e-Allergy screening (premedical system of early diagnosis of allergy and asthma based on online tools). These tools are combined with a clinical decision support system (CDSS) and are available in many languages. An e-CRF and an e-learning tool complete MASK. MASK is flexible and other tools can be added. It appears to be an advanced, global and integrated ICT answer for many unmet needs in allergic diseases which will improve policies and standards. © 2015 John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • No Thumbnail Available
    Item
    Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
    (BioMed Central Ltd., 2016) Bousquet J.; Farrell J.; Crooks G.; Hellings P.; Bel E.H.; Bewick M.; Chavannes N.H.; De Sousa J.C.; Cruz A.A.; Haahtela T.; Joos G.; Khaltaev N.; Malva J.; Muraro A.; Nogues M.; Palkonen S.; Pedersen S.; Robalo-Cordeiro C.; Samolinski B.; Strandberg T.; Valiulis A.; Yorgancioglu A.; Zuberbier T.; Bedbrook A.; Aberer W.; Adachi M.; Agusti A.; Akdis C.A.; Akdis M.; Ankri J.; Alonso A.; Annesi-Maesano I.; Ansotegui I.J.; Anto J.M.; Arnavielhe S.; Arshad H.; Bai C.; Baiardini I.; Bachert C.; Baigenzhin A.K.; Barbara C.; Bateman E.D.; Beghé B.; Kheder A.B.; Bennoor K.S.; Benson M.; Bergmann K.C.; Bieber T.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Blasi F.; Boner A.L.; Bonini M.; Bonini S.; Bosnic-Anticevitch S.; Boulet L.P.; Bourret R.; Bousquet P.J.; Braido F.; Briggs A.H.; Brightling C.E.; Brozek J.; Buhl R.; Burney P.G.; Bush A.; Caballero-Fonseca F.; Caimmi D.; Calderon M.A.; Calverley P.M.; Camargos P.A.M.; Canonica G.W.; Camuzat T.; Carlsen K.H.; Carr W.; Carriazo A.; Casale T.; Cepeda Sarabia A.M.; Chatzi L.; Chen Y.Z.; Chiron R.; Chkhartishvili E.; Chuchalin A.G.; Chung K.F.; Ciprandi G.; Cirule I.; Cox L.; Costa D.J.; Custovic A.; Dahl R.; Dahlen S.E.; Darsow U.; De Carlo G.; De Blay F.; Dedeu T.; Deleanu D.; De Manuel Keenoy E.; Demoly P.; Denburg J.A.; Devillier P.; Didier A.; Dinh-Xuan A.T.; Djukanovic R.; Dokic D.; Douagui H.; Dray G.; Dubakiene R.; Durham S.R.; Dykewicz M.S.; El-Gamal Y.; Emuzyte R.; Fabbri L.M.; Fletcher M.; Fiocchi A.; Fink Wagner A.; Fonseca J.; Fokkens W.J.; Forastiere F.; Frith P.; Gaga M.; Gamkrelidze A.; Garces J.; Garcia-Aymerich J.; Gemicioǧlu B.; Gereda J.E.; González Diaz S.; Gotua M.; Grisle I.; Grouse L.; Gutter Z.; Guzmán M.A.; Heaney L.G.; Hellquist-Dahl B.; Henderson D.; Hendry A.; Heinrich J.; Heve D.; Horak F.; Hourihane J.O.B.; Howarth P.; Humbert M.; Hyland M.E.; Illario M.; Ivancevich J.C.; Jardim J.R.; Jares E.J.; Jeandel C.; Jenkins C.; Johnston S.L.; Jonquet O.; Julge K.; Jung K.S.; Just J.; Kaidashev I.P.; Kaitov M.R.; Kalayci O.; Kalyoncu A.F.; Keil T.; Keith P.K.; Klimek L.; Koffi N'Goran B.; Kolek V.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kuna P.; Kvedariene V.; Lambrecht B.; Lau S.; Larenas-Linnemann D.; Laune D.; Le L.T.T.; Lieberman P.; Lipworth B.; Li J.; Lodrup Carlsen K.; Louis R.; MacNee W.; Magard Y.; Magnan A.; Mahboub B.; Mair A.; Majer I.; Makela M.J.; Manning P.; Mara S.; Marshall G.D.; Masjedi M.R.; Matignon P.; Maurer M.; Mavale-Manuel S.; Melén E.; Melo-Gomes E.; Meltzer E.O.; Menzies-Gow A.; Merk H.; Michel J.P.; Miculinic N.; Mihaltan F.; Milenkovic B.; Mohammad G.M.Y.; Molimard M.; Momas I.; Montilla-Santana A.; Morais-Almeida M.; Morgan M.; Mösges R.; Mullol J.; Nafti S.; Namazova-Baranova L.; Naclerio R.; Neou A.; Neffen H.; Nekam K.; Niggemann B.; Ninot G.; Nyembue T.D.; O'Hehir R.E.; Ohta K.; Okamoto Y.; Okubo K.; Ouedraogo S.; Paggiaro P.; Pali-Schöll I.; Panzner P.; Papadopoulos N.; Papi A.; Park H.S.; Passalacqua G.; Pavord I.; Pawankar R.; Pengelly R.; Pfaar O.; Picard R.; Pigearias B.; Pin I.; Plavec D.; Poethig D.; Pohl W.; Popov T.A.; Portejoie F.; Potter P.; Postma D.; Price D.; Rabe K.F.; Raciborski F.; Radier Pontal F.; Repka-Ramirez S.; Reitamo S.; Rennard S.; Rodenas F.; Roberts J.; Roca J.; Rodriguez Mañas L.; Rolland C.; Roman Rodriguez M.; Romano A.; Rosado-Pinto J.; Rosario N.; Rosenwasser L.; Rottem M.; Ryan D.; Sanchez-Borges M.; Scadding G.K.; Schunemann H.J.; Serrano E.; Schmid-Grendelmeier P.; Schulz H.; Sheikh A.; Shields M.; Siafakas N.; Sibille Y.; Similowski T.; Simons F.E.R.; Sisul J.C.; Skrindo I.; Smit H.A.; Solé D.; Sooronbaev T.; Spranger O.; Stelmach R.; Sterk P.J.; Sunyer J.; Thijs C.; To T.; Todo-Bom A.; Triggiani M.; Valenta R.; Valero A.L.; Valia E.; Valovirta E.; Van Ganse E.; Van Hage M.; Vandenplas O.; Vasankari T.; Vellas B.; Vestbo J.; Vezzani G.; Vichyanond P.; Viegi G.; Vogelmeier C.; Vontetsianos T.; Wagenmann M.; Wallaert B.; Walker S.; Wang D.Y.; Wahn U.; Wickman M.; Williams D.M.; Williams S.; Wright J.; Yawn B.P.; Yiallouros P.K.; Yusuf O.M.; Zaidi A.; Zar H.J.; Zernotti M.E.; Zhang L.; Zhong N.; Zidarn M.; Mercier J.
    Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing. © 2016 The Author(s).
  • No Thumbnail Available
    Item
    Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)
    (BioMed Central Ltd., 2017) Bousquet J.; Farrell J.; Crooks G.; Hellings P.; Bel E.H.; Bewick M.; Chavannes N.H.; De Sousa J.C.; Cruz A.A.; Haahtela T.; Joos G.; Khaltaev N.; Malva J.; Muraro A.; Nogues M.; Palkonen S.; Pedersen S.; Robalo-Cordeiro C.; Samolinski B.; Strandberg T.; Valiulis A.; Yorgancioglu A.; Zuberbier T.; Bedbrook A.; Aberer W.; Adachi M.; Agusti A.; Akdis C.A.; Akdis M.; Ankri J.; Alonso A.; Annesi-Maesano I.; Ansotegui I.J.; Anto J.M.; Arnavielhe S.; Arshad H.; Bai C.; Baiardini I.; Bachert C.; Baigenzhin A.K.; Barbara C.; Bateman E.D.; Beghé B.; Kheder A.B.; Bennoor K.S.; Benson M.; Bergmann K.C.; Bieber T.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Blasi F.; Boner A.L.; Bonini M.; Bonini S.; Bosnic-Anticevitch S.; Boulet L.P.; Bourret R.; Bousquet P.J.; Braido F.; Briggs A.H.; Brightling C.E.; Brozek J.; Buhl R.; Burney P.G.; Bush A.; Caballero-Fonseca F.; Caimmi D.; Calderon M.A.; Calverley P.M.; Camargos P.A.M.; Canonica G.W.; Camuzat T.; Carlsen K.H.; Carr W.; Carriazo A.; Casale T.; Cepeda Sarabia A.M.; Chatzi L.; Chen Y.Z.; Chiron R.; Chkhartishvili E.; Chuchalin A.G.; Chung K.F.; Ciprandi G.; Cirule I.; Cox L.; Costa D.J.; Custovic A.; Dahl R.; Dahlen S.E.; Darsow U.; De Carlo G.; De Blay F.; Dedeu T.; Deleanu D.; De Manuel Keenoy E.; Demoly P.; Denburg J.A.; Devillier P.; Didier A.; Dinh-Xuan A.T.; Djukanovic R.; Dokic D.; Douagui H.; Dray G.; Dubakiene R.; Durham S.R.; Dykewicz M.S.; El-Gamal Y.; Emuzyte R.; Fabbri L.M.; Fletcher M.; Fiocchi A.; Fink Wagner A.; Fonseca J.; Fokkens W.J.; Forastiere F.; Frith P.; Gaga M.; Gamkrelidze A.; Garces J.; Garcia-Aymerich J.; Gemicioǧlu B.; Gereda J.E.; González Diaz S.; Gotua M.; Grisle I.; Grouse L.; Gutter Z.; Guzmán M.A.; Heaney L.G.; Hellquist-Dahl B.; Henderson D.; Hendry A.; Heinrich J.; Heve D.; Horak F.; Hourihane J.O.B.; Howarth P.; Humbert M.; Hyland M.E.; Illario M.; Ivancevich J.C.; Jardim J.R.; Jares E.J.; Jeandel C.; Jenkins C.; Johnston S.L.; Jonquet O.; Julge K.; Jung K.S.; Just J.; Kaidashev I.P.; Khaitov M.R.; Kalayci O.; Kalyoncu A.F.; Keil T.; Keith P.K.; Klimek L.; Koffi N'Goran B.; Kolek V.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kuna P.; Kvedariene V.; Lambrecht B.; Lau S.; Larenas-Linnemann D.; Laune D.; Le L.T.T.; Lieberman P.; Lipworth B.; Li J.; Lodrup Carlsen K.; Louis R.; MacNee W.; Magard Y.; Magnan A.; Mahboub B.; Mair A.; Majer I.; Makela M.J.; Manning P.; Mara S.; Marshall G.D.; Masjedi M.R.; Matignon P.; Maurer M.; Mavale-Manuel S.; Melén E.; Melo-Gomes E.; Meltzer E.O.; Menzies-Gow A.; Merk H.; Michel J.P.; Miculinic N.; Mihaltan F.; Milenkovic B.; Mohammad G.M.Y.; Molimard M.; Momas I.; Montilla-Santana A.; Morais-Almeida M.; Morgan M.; Mösges R.; Mullol J.; Nafti S.; Namazova-Baranova L.; Naclerio R.; Neou A.; Neffen H.; Nekam K.; Niggemann B.; Ninot G.; Nyembue T.D.; O'Hehir R.E.; Ohta K.; Okamoto Y.; Okubo K.; Ouedraogo S.; Paggiaro P.; Pali-Schöll I.; Panzner P.; Papadopoulos N.; Papi A.; Park H.S.; Passalacqua G.; Pavord I.; Pawankar R.; Pengelly R.; Pfaar O.; Picard R.; Pigearias B.; Pin I.; Plavec D.; Poethig D.; Pohl W.; Popov T.A.; Portejoie F.; Potter P.; Postma D.; Price D.; Rabe K.F.; Raciborski F.; Radier Pontal F.; Repka-Ramirez S.; Reitamo S.; Rennard S.; Rodenas F.; Roberts J.; Roca J.; Rodriguez Mañas L.; Rolland C.; Roman Rodriguez M.; Romano A.; Rosado-Pinto J.; Rosario N.; Rosenwasser L.; Rottem M.; Ryan D.; Sanchez-Borges M.; Scadding G.K.; Schunemann H.J.; Serrano E.; Schmid-Grendelmeier P.; Schulz H.; Sheikh A.; Shields M.; Siafakas N.; Sibille Y.; Similowski T.; Simons F.E.R.; Sisul J.C.; Skrindo I.; Smit H.A.; Solé D.; Sooronbaev T.; Spranger O.; Stelmach R.; Sterk P.J.; Sunyer J.; Thijs C.; To T.; Todo-Bom A.; Triggiani M.; Valenta R.; Valero A.L.; Valia E.; Valovirta E.; Van Ganse E.; Van Hage M.; Vandenplas O.; Vasankari T.; Vellas B.; Vestbo J.; Vezzani G.; Vichyanond P.; Viegi G.; Vogelmeier C.; Vontetsianos T.; Wagenmann M.; Wallaert B.; Walker S.; Wang D.Y.; Wahn U.; Wickman M.; Williams D.M.; Williams S.; Wright J.; Yawn B.P.; Yiallouros P.K.; Yusuf O.M.; Zaidi A.; Zar H.J.; Zernotti M.E.; Zhang L.; Zhong N.; Zidarn M.; Mercier J.
    [No abstract available]
  • No Thumbnail Available
    Item
    Aria 2016 executive summary: Integrated care pathways for predictive medicine across the life cycle; [ARIA 2016 yönetici özeti: Yaşam döngüsü boyunca hastalıkları öngörmeye yönelik tıp uygulamaları için bütünleştirilmiş yaklaşım yolakları]
    (Ankara University, 2017) Yorgancioğlu A.A.; Kalayci Ö.; Cingi C.; Gemicioğlu B.; Kalyoncu A.F.; Agache I.; Bachert C.; Bedbrook A.; Canonica G.W.; Casale T.; Cruz A.; Fokkens W.E.; Hellings P.; Samolinski B.; Bousquet J.
    The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA-disseminated and implemented in over 70 countries globally- is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK (MACVIA (Contre les MAladies Chroniques pour un VIeillissement Actif)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multidisciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease. © 2017, Ankara University. All rights reserved.
  • No Thumbnail Available
    Item
    MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
    (BioMed Central Ltd., 2018) Bousquet J.; Arnavielhe S.; Bedbrook A.; Bewick M.; Laune D.; Mathieu-dupas E.; Murray R.; Onorato G.L.; Pépin J.L.; Picard R.; Portejoie F.; Costa E.; Fonseca J.; Lourenço O.; Morais-Almeida M.; Todo-bom A.; Cruz A.A.; Silva J.D.; Serpa F.S.; Illario M.; Menditto E.; Cecchi L.; Monti R.; Napoli L.; Ventura M.T.; De Feo G.; Larenas-linnemann D.; Fuentes Perez M.; Huerta Villabolos Y.R.; Rivero-yeverino D.; Rodriguez-zagal E.; Amat F.; Annesi-maesano I.; Bosse I.; Demoly P.; Devillier P.; Fontaine J.F.; Just J.; Kuna T.P.; Samolinski B.; Valiulis A.; Emuzyte R.; Kvedariene V.; Ryan D.; Sheikh A.; Schmidt-grendelmeier P.; Klimek L.; Pfaar O.; Bergmann K.C.; Mösges R.; Zuberbier T.; Roller-wirnsberger R.E.; Tomazic P.; Fokkens W.J.; Chavannes N.H.; Reitsma S.; Anto J.M.; Cardona V.; Dedeu T.; Mullol J.; Haahtela T.; Salimäki J.; Toppila-Salmi S.; Valovirta E.; Gemicioğlu B.; Yorgancioglu A.; Papadopoulos N.; Prokopakis E.P.; Bosnic-anticevich S.; O’hehir R.; Ivancevich J.C.; Neffen H.; Zernotti E.; Kull I.; Melen E.; Wickman M.; Bachert C.; Hellings P.; Palkonen S.; Bindslev-jensen C.; Eller E.; Waserman S.; Sova M.; De Vries G.; van Eerd M.; Agache I.; Casale T.; Dykewickz M.; Naclerio R.N.; Okamoto Y.; Wallace D.V.; Aberer W.; Akdis C.A.; Akdis M.; Alberti M.R.; Almeida R.; Angles R.; Ansotegui I.J.; Arnavielle S.; Asayag E.; Asarnoj A.; Arshad H.; Avolio F.; Bacci E.; Baiardini I.; Barbara C.; Barbagallo M.; Baroni I.; Barreto B.A.; Basagana X.; Bateman E.D.; Bedolla-Barajas M.; Beghé B.; Bel E.H.; Bennoor K.S.; Benson M.; Bertorello L.; Białoszewski A.Z.; Bieber T.; Bialek S.; Bjermer L.; Blain H.; Blasi F.; Blua A.; Bochenska Marciniak M.; Bogus-Buczynska I.; Boner A.L.; Bonini M.; Bonini S.; Bosnic-Anticevich C.S.; Bouchard J.; Boulet L.P.; Bourret R.; Bousquet P.J.; Braido F.; Briedis V.; Brightling C.E.; Brozek J.; Bucca C.; Buhl R.; Buonaiuto R.; Panaitescu C.; Burguete Cabañas M.T.; Burte E.; Bush A.; Caballero-Fonseca F.; Caillot D.; Caimmi D.; Calderon M.A.; Camargos P.A.M.; Camuzat T.; Canfora G.; Canonica G.W.; Carlsen K.H.; Carreiro-Martins P.; Carriazo A.M.; Carr W.; Cartier C.; Castellano G.; Cepeda A.M.; Chen Y.; Chiron R.; Chivato T.; Chkhartishvili E.; Chuchalin A.G.; Chung K.F.; Ciaravolo M.M.; Ciceran A.; Cingi C.; Ciprandi G.; Carvalho Coehlo A.C.; Colas L.; Colgan E.; Coll J.; Conforti D.; Correia de Sousa J.; Cortés-Grimaldo R.M.; Corti F.; Costa-Dominguez M.C.; Courbis A.L.; Cox L.; Crescenzo M.; Custovic A.; Czarlewski W.; Dahlen S.E.; Dario C.; da Silva J.; Dauvilliers Y.; Darsow U.; De Blay F.; De Carlo G.; de Fátima Emerson M.; De Martino B.; de Paula Motta Rubini N.; Deleanu D.; Denburg J.A.; Di Capua Ercolano S.; Di Carluccio N.; Didier A.; Dokic D.; Dominguez-Silva M.G.; Douagui H.; Dray G.; Dubakiene R.; Durham S.R.; Du Toit G.; Dykewicz M.S.; El-Gamal Y.; Eklund P.; Farrell J.; Farsi A.; Ferreira de Mello J., Jr.; Ferrero J.; Fink-Wagner A.; Fiocchi A.; Fonseca J.A.; Forti S.; Fuentes-Perez J.M.; Gálvez-Romero J.L.; Gamkrelidze A.; Garcia-Aymerich J.; García-Cobas C.Y.; Garcia-Cruz M.H.; Genova S.; George C.; Gereda J.E.; Gerth van Wijk R.; Gomez R.M.; Gómez-Vera J.; González Diaz S.; Gotua M.; Grisle I.; Guidacci M.; Guldemond N.A.; Gutter Z.; Guzmán M.A.; Hajjam J.; Hernández L.; Hourihane J.O.’.B.; Huerta-Villalobos Y.R.; Humbert M.; Iaccarino G.; Jares E.J.; Jassem E.; Johnston S.L.; Joos G.; Jung K.S.; Jutel M.; Kaidashev I.; Kalayci O.; Kalyoncu A.F.; Karjalainen J.; Kardas P.; Keil T.; Keith P.K.; Khaitov M.; Khaltaev N.; Kleine-Tebbe J.; Kowalski M.L.; Kuitunen M.; Kuna P.; Kupczyk M.; Krzych-Fałta E.; Lacwik P.; Lauri D.; Lavrut J.; Le L.T.T.; Lessa M.; Levato G.; Li J.; Lieberman P.; Lipiec A.; Lipworth B.; Lodrup Carlsen K.C.; Louis R.; Luna-Pech J.A.; Maciej K.; Magnan A.; Mahboub B.; Maier D.; Mair A.; Majer I.; Malva J.; Mandajieva E.; Manning P.; De Manuel Keenoy E.; Marshall G.D.; Masjedi M.R.; Maspero J.F.; Matta Campos J.J.; Matos A.L.; Maurer M.; Mavale-Manuel S.; Mayora O.; Melén E.; Melo-Gomes E.; Meltzer E.O.; Mercier J.; Miculinic N.; Mihaltan F.; Milenkovic B.; Moda G.; Mogica-Martinez M.D.; Mohammad Y.; Momas I.; Montefort S.; Mora Bogado D.; Morato-Castro F.F.; Mota-Pinto A.; Moura Santo P.; Münter L.; Naclerio R.; Nadif R.; Nalin M.; Namazova-Baranova L.; Niedeberger V.; Nekam K.; Neou A.; Nieto A.; Nogueira-Silva L.; Nogues M.; Novellino E.; Nyembue T.D.; O’hehir R.E.; Odzhakova C.; Ohta K.; Okubo K.; Ortega Cisneros M.; Ouedraogo S.; Pali-Schöll I.; Panzner P.; Papadopoulos N.G.; Park H.S.; Papi A.; Passalacqua G.; Paulino E.; Pawankar R.; Pedersen S.; Pereira A.M.; Persico M.; Phillips J.; Pigearias B.; Pin I.; Pitsios C.; Plavec D.; Pohl W.; Popov T.A.; Potter P.; Pozzi A.C.; Price D.; Puy R.; Pugin B.; Pulido Ross R.E.; Przemecka M.; Rabe K.F.; Raciborski F.; Rajabian-Soderlund R.; Ribeirinho I.; Rimmer J.; Rizzo J.A.; Rizzo M.C.; Robalo-Cordeiro C.; Rodenas F.; Rodo X.; Rodriguez Gonzalez M.; Rodriguez-Mañas L.; Rolland C.; Rodrigues Valle S.; Roman Rodriguez M.; Romano A.; Rolla G.; Romano M.; Rosado-Pinto J.; Rosario N.; Rottem M.; Sagara H.; Sanchez-Borges M.; Sastre-Dominguez J.; Scadding G.K.; Schunemann H.J.; Scichilone N.; Schmid-Grendelmeier P.; Shamai S.; Sierra M.; Simons F.E.R.; Siroux V.; Sisul J.C.; Skrindo I.; Solé D.; Somekh D.; Sondermann M.; Sooronbaev T.; Sorensen M.; Sorlini M.; Spranger O.; Stellato C.; Stelmach R.; Stukas R.; Sunyer J.; Strozek J.; Szylling A.; Tebyriçá J.N.; Thibaudon M.; Tomazic P.V.; Trama U.; Triggiani M.; Suppli Ulrik C.; Urrutia-Pereira M.; Valenta R.; Valero A.; van Ganse E.; van Hague M.; Vandenplas O.; Vezzani G.; Vasankari T.; Vatrella A.; Verissimo M.T.; Viart F.; Viegi G.; Vicheva D.; Vontetsianos T.; Wagenmann M.; Wallace D.; Wang D.Y.; Werfel T.; Westman M.; Williams D.M.; Williams S.; Wilson N.; Wright J.; Wroczynski P.; Yakovliev P.; Yawn B.P.; Yiallouros P.K.; Yusuf O.M.; Zar H.J.; Zhang L.; Zhong N.; Zernotti M.E.; Zidarn M.; Zubrinich C.; Zurkuhlen A.
    mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary. © 2018 The Author(s).
  • No Thumbnail Available
    Item
    Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
    (Blackwell Publishing Ltd, 2019) Agache I.; Annesi-Maesano I.; Bonertz A.; Branca F.; Cant A.; Fras Z.; Ingenrieth F.; Namazova-Baranova L.; Odemyr M.; Spanevello A.; Vieths S.; Yorgancioglu A.; Alvaro-Lozano M.; Barber Hernandez D.; Chivato T.; Del Giacco S.; Diamant Z.; Eguiluz-Gracia I.; van Wijk R.G.; Gevaert P.; Graessel A.; Hellings P.; Hoffmann-Sommergruber K.; Jutel M.; Lau S.; Lauerma A.; Maria Olaguibel J.; O'Mahony L.; Ozdemir C.; Palomares O.; Pfaar O.; Sastre J.; Scadding G.; Schmidt-Weber C.; Schmid-Grendelmeier P.; Shamji M.; Skypala I.; Spinola M.; Spranger O.; Torres M.; Vereda A.; Bonini S.
    The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics. © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • No Thumbnail Available
    Item
    2019 ARIA care pathways for allergic rhinitis-Turkey; [ARIA 2019, allerjik rinite tedavi yaklaşımı-Türkiye]
    (AVES, 2020) Yorgancıoğlu A.A.; Gemicioğlu B.; Cingi C.; Kalaycı Ö.; Kalyoncu A.F.; Bachert C.; Hellings P.; Pfaar O.; Schünemann H.J.; Wallace D.; Bedbrook A.; Czarlewski W.; Bousquet J.
    The evaluation of real-life integrated care pathways (ICPs) was recommended for digitally enabled, integrated, person-centered care for rhinitis and asthma multimorbidity embedding environmental exposure. ICPs are structured multidisciplinary care plans detailing key steps of patient care. They promote the translation of guideline recommendations into local protocols and their application to clinical practice. In allergic rhinitis, there is an urgent need to develop next-generation guidelines for pharmacotherapy and ICPs for allergen immunotherapy. A meeting was held in Paris on December 3, 2018, during which two separate documents were produced. An executive summary is presented in this article, which will be customized in different countries or regions in order to adjust the conclusions of the papers for local use and health systems. © 2020 by Turkish Thoracic Society.